RXO Inc. downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded RXO Inc. (RXO) to Perform from Outperform without a price target The firm says that considering increased economic ...
Barclays Reaffirms Their Buy Rating on RXO, Inc. (RXO)
In a report released today, Brandon Oglenski from Barclays maintained a Buy rating on RXO, Inc. (RXO – Research Report), with a price target of ...